Screener
United Therapeutics UTHR Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $333M+7.6% | $274.9M-14.7% | $364.3M+20.9% | $338.7M+9.6% | $309.5M+11.3% | ||
| $24.2M+14.7% | $22.6M+14.1% | $22.8M+15.7% | $21.9M+14.7% | $21.1M+12.8% | ||
| $43.4M+14.8% | $33.9M+6.6% | $39M+44.4% | $39.1M-6.2% | $37.8M-23.9% | ||
| $313.6M+63.6% | $463.3M+0.5% | $346.2M+1.5% | $562.1M+49.0% | $191.7M-17.4% | ||
| $108M+73.6% | $100.8M+34.6% | $172.9M+99.4% | $210.5M+175% | $62.2M+37.9% | ||
| $87.5M+129% | $743.7M+552% | -$227.6M— | —— | -$299.9M— | ||
| —— | $1.5B— | $0— | $1B— | $0— | ||
| —— | —— | $50M— | $50M— | $50M— | ||
| $0-100% | $0-100% | —— | —— | $400M+300% | ||
| —— | -$1.48B-1,483% | $0+100% | -$956M-1,391% | -$198.6M-314% | ||
| $523.5M+271% | -$277.4M-237% | —— | -$253M-228% | -$306.8M-394% | ||
| $205.6M+58.8% | $362.5M-6.2% | $173.3M-31.9% | $351.6M+16.9% | $129.5M-30.8% |
FAQ
- How much cash does United Therapeutics generate?
- United Therapeutics (UTHR) generated $1.7B in operating cash flow over the trailing twelve months.
- What is United Therapeutics's free cash flow?
- After $592.2M of capital expenditures, United Therapeutics's free cash flow was $1.1B over the trailing twelve months, up 2.1% year over year.
- Where does United Therapeutics's cash flow data come from?
- Every line is extracted from United Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
